| Line Item | 2024-03-31 | Y/Y |
|---|---|---|
| R&D Expense | $29K | -38.0% |
| SG&A Expense | $252K | +265.5% |
| Operating Income | -$2.1M | -11.1% |
| Net Income | -$2.4M | -36.3% |
| Line Item | 2024-03-31 | Y/Y |
|---|---|---|
| Inventory | $1K | +2.3% |
| Current Assets | $4K | -98.5% |
| Total Assets | $4K | -100.0% |
| Current Liabilities | $1.3M | -37.3% |
| Total Liabilities | $1.3M | -41.6% |
| Stockholders' Equity | -$1.3M | -113.2% |
| Line Item | 2024-03-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$1.4M | -39.2% |
| Financing Cash Flow | $1.5M | +21.2% |